Authors
Biniyam Tefera Deressa, Thatcher Zinabu Akele, Wasie Gebi, Girum Tessema Zingeta, Ibrahim Oluwaseun Ahmed
Published in
Journal of medical case reports. Volume 20. Issue 1. Aug 16, 2026. Epub Aug 16, 2026.
Abstract
Cancer treatments, such as surgery, chemotherapy, and radiotherapy, as well as cancer itself, commonly result in anemia. As a result, patients frequently require blood transfusions to maintain an optimal hemoglobin level. However, blood transfusion has its own set of adverse reactions, which can range from minor to life-threatening complications, such as hemolytic transfusion reaction, transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO). The exact incidence of transfusion reactions in cancer patients is not well-known. In earlier reports, the overall incidence is 0.3%. However, to the best of the author's knowledge, there is no published report of isolated ocular blood transfusion reaction in Ethiopia. Here, we report the presentation of an infrequent adverse event and its management.
A 51-year-old man with castration-resistant prostate cancer and severe anemia (hemoglobin concentration of 6.2 g/dl). Packed red-cell transfusion was started after grouping and cross-matching. After about 250 ml of the blood had been transfused, he suddenly felt severe pain and discomfort in both eyes, with associated photophobia and conjunctival edema. Ocular examination revealed edematous and engorged conjunctivae with thick mucinous coverage. The rest of the examinations were non-revealing. Based on the absence of fever, chills, hypotension, respiratory distress, abdominal pain, jaundice, or change in the urine color on this presentation, acute hemolytic transfusion reaction, TACO, and TRALI were considered clinically unlikely. Transfusion was immediately discontinued; intravenous and topical steroid was applied. Signs and symptoms resolved completely within 8 h and was discharged home the following day after observation.
We have reported a probable case of isolated ocular surface blood transfusion reaction. Despite the fact that this complication is extremely rare. Prompt discontinuation of transfusion and administration of systemic and topical steroids led to rapid resolution; however, no standardized protocol exists for this rare entity.
PMID:
43015904
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 2
- Comments 0